Home > PJ (current issue) > News / Daily News | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 269 No 7207 p87-92
20 July 2002


News summary

PSNC waits for new Minister over offer A remuneration offer for community pharmacy in England is awaiting Ministerial approval, but has probably been delayed by the recent appointment of David Lammy as Parliamentary Under-Secretary of State for Health...[more]

PSNC foresees problems with draft LPS rules as bids are delayed Draft regulations for local pharmaceutical services (LPS) pilots have a serious flaw, according to the Pharmaceutical Services Negotiating Committee...[more]

NICE seeks clinical pharmacists for appraisal committee The National Institute for Clinical Excellence is seeking two clinical pharmacists to join its independent appraisal committee, replacing members whose terms of service have finished...[more]

Society proposals ignore its Royal Charter and fail on proper professional representation, PSNC says Any proposals to change the structure of the Royal Pharmaceutical Society's Council should uphold its Royal Charter and ensure satisfactory professional representation, the Pharmaceutical Services Negotiating Committee believes. Current propositions from the Society's modernisation steering group do neither, it says...[more]

CCA appoints first executives The Company Chemists Association has appointed Colin Baldwin as its first chief executive and Mike Keen as head of marketing and operations...[more]

GPs more likely to recommend OTCs General practitioners are now eight times more likely to recommend patients with minor ailments to use non-prescription medicines than they were five years ago, according to new research from the Proprietary Association of Great Britain...[more]

GPs say "yes" to new contract General practitioners have voted in favour of a new GP contract...[more]

Donepezil trial raises ethical questions The results of a trial which suggest that donepezil (Aricept) helps pilots retain skills they have learnt during training have raised questions about cognitive enhancement of healthy people...[more]

No immediate changes to HRT are necessary, says Health Department Results of the Women's Health Initiative study reported last week do not necessitate any immediate changes to the treatment of women receiving hormone replacement therapy (HRT), says the Department of Health...[more]

Public asked about genetic testing A consultation process has been launched by the Human Genetics Commission on whether genetic or gene testing kits should be available direct to the public...[more]

Pharmacists in NI support CPD, but few practise it fully Almost 90 per cent of pharmacists who responded to a survey in Northern Ireland believe that it is essential for all practising pharmacists to participate in continuing professional development (CPD). However, few of them practise the full CPD cycle...[more]

Two protease inhibitors better than one after failure of previous HIV treatment Using two new protease inhibitors as part of a salvage regimen to treat HIV-infected patients whose previous regimen has failed is better than using one new protease inhibitor, say researchers...[more]

Caution required with atypical antipsychotic drugs Atypical antipsychotic drugs are only a modest improvement over older antipsychotic drugs and will not be suitable for all patients, according to Professor Robin Murray, professor of psychiatry, Institute of Psychiatry, London...[more]

Benefits of long-term growth hormone are unclear Benefits of long-term treatment with growth hormone are unclear and data only support treatment of patients with severely and permanently altered growth hormone secretion, a study published in the BMJ shows. However, the study is criticised for not taking into account that the subjects received too little growth hormone too late...[more]

Commonwealth Games countdown The XVII Commonwealth Games begin in Manchester on 25 July...[more]

Take-over of Pharmacia could lead to more mergers Pfizer's $60bn (£40bn) take-over of Pharmacia could lead to a further round of mergers among pharmaceutical companies...[more]

Introduction of one-stop health centres worries local pharmacists in Ireland One-stop health centres being introduced in the Irish Republic, under public-private partnership schemes, are causing concern to local pharmacists, who fear their livelihoods could be threatened...[more]

Nucare offers retail support to members Nucare is to offer its members a merchandising service as part of a new retail support programme for members...[more]

Aspirin plus anticoagulant better than aspirin alone after coronary events Intensive treatment with an anticoagulant or treatment with aspirin plus an anticoagulant is more effective than aspirin alone in reducing cardiovascular events following myocardial infarction or unstable angina, say researchers from the Netherlands...[more]

First case of VRSA in United States The first case of <I>Staphylococcus aureus </I>with high-level resistance to the antibiotic vancomycin has been reported in the United States, according to the Public Health Laboratory Service, London...[more]

Prescribers need to address the problem of antibiotic resistance The problem of antibiotic resistance needs to be addressed by both prescribers and politicians, not just at a research level, Professor Sebastian Amyes, department of medical microbiology, University of Edinburgh, said at a symposium on anti-infectives held in London...[more]

New antifungal launched...[more]

Peginterferon alfa-2a launched...[more]

AAH forecasts the weather...[more]

ETP evaluation...[more]

Back to Top

  * PDF files on PJ Online require Acrobat Reader 4 or later.


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal